首页/数据集/SUMO-2/3 ChIP-Seq in HL-60 cells treated or not with Daunorubicin, Cytarabin and the Nox inhibitor VAS2870

SUMO-2/3 ChIP-Seq in HL-60 cells treated or not with Daunorubicin, Cytarabin and the Nox inhibitor VAS2870

ChEBI2023-12-30 更新2026-07-12 收录

癌症药物表观遗传学

ChIP-Seq基因组调控

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MTAB-4947 数据链接链接失效反馈

官方服务：

资源简介：

SUMO-2/3 ChIP-Seq in HL-60 cells treated or not with Daunorubicin, Cytarabin and the Nox inhibitor VAS2870

应用场景：

创建时间：

2023-12-30

急性早幼粒细胞白血病

ChIP-Seq基因组调控

ChIP-Seq data for 1 Acute Promyelocytic Leukemia - MC2884 (4h) sample(s). 6 run(s), 6 experiment(s), 6 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation

NIAID Data Ecosystem60

Genome profiling of HA-hWDR5 binding in mouse embryonic bodies using SFEBq differetiation methods. Genome profiling of HA-hWDR5 binding in mouse embryonic bodies using SFEBq differetiation methods

发育表观遗传学

ChIP-Seq基因组调控

This study describes the binding profile of HA-hWDR5 in mouse embryonic bodies with early (T12h) and late (T48h) rescue of HA-hWDR5 Overall design: ChIP-Seq profile of HA-hWDR5 in day 6 embryonic embr

NIAID Data Ecosystem50

Identification of Biologically Relevant Enhancers in Human Erythroid Cells [ChIP-Seq]

红细胞研究

ChIP-Seq基因组调控

Identification of cell-type specific enhancers is important for understanding the regulation of programs controlling cellular development and differentiation. Enhancers are typically marked by the co-

NIAID Data Ecosystem40

Comprehensive identification and characterization of the binding sites of RNA polymerase II

RNA聚合酶结合位点

ChIP-Seq基因组调控

We comprehensively identified and characterized the binding sites of RNA polymerase II in the human genome. We used the ChIP-Seq method in which chromatin-immunoprecipitation (ChIP) assay and deep seq

NIAID Data Ecosystem60

Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [ChIP-Seq]

前列腺癌靶向治疗

ChIP-Seq基因组调控

Targeting the activation function-1 (AF-1) at the N-terminus of the androgen receptor (AR) is an attractive therapeutic alternative to the current approaches to inhibit AR action in prostate cancer (P

NIAID Data Ecosystem50

SUMO-2/3 ChIP-Seq in HL-60 cells treated or not with Daunorubicin, Cytarabin and the Nox inhibitor VAS2870

资源简介：

相关数据集